Used primarily in organic synthesis, this compound serves as a key intermediate in the development of pharmaceuticals, particularly in the creation of enzyme inhibitors and receptor modulators. Its boronic acid group enables it to participate in Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds in drug discovery. Additionally, it is employed in the synthesis of biologically active molecules targeting diseases such as cancer, inflammation, and metabolic disorders. Its morpholine moiety enhances solubility and bioavailability, making it valuable in optimizing drug candidates for therapeutic applications.